+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

BioFire Diagnostics Inc - Product Pipeline Analysis, 2020 Update

FEATURED COMPANIES

  • Edge Biologicals, Inc.
  • Erba Diagnostics Inc
  • Remel Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

BioFire Diagnostics Inc (BioFire Diagnostics), formerly Idaho Technology Inc, a subsidiary of bioMerieux SA, is a molecular diagnostics company. The company’s product portfolio includes filmarray torch that provides solutions for infectious disease molecular diagnostics. It also provides wide range of panels to detect several pathogens including viruses, bacteria, parasites, and yeast in respiratory, meningitis and encephalitis me, blood culture identification BCID and gastro intestines. BioFire Diagnostics carries out research on molecular diagnostics and medical technologies. The company operates as a subsidiary of bioMerieux SA. BioFire Diagnostics is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company BioFire Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Edge Biologicals, Inc.
  • Erba Diagnostics Inc
  • Remel Inc
BioFire Diagnostics Inc Company Overview
  • BioFire Diagnostics Inc Company Snapshot
  • BioFire Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • BioFire Diagnostics Inc – Pipeline Analysis Overview
  • BioFire Diagnostics Inc - Key Facts
  • BioFire Diagnostics Inc - Major Products and Services
  • BioFire Diagnostics Inc Pipeline Products by Development Stage
  • BioFire Diagnostics Inc Ongoing Clinical Trials by Trial Status
BioFire Diagnostics Inc Pipeline Products Overview
  • Diagnostic Test - Acute Respiratory Infection
  • Diagnostic Test - Acute Respiratory Infection Product Overview
  • FilmArray 2.0 - Lower Respiratory Tract Panel
  • FilmArray 2.0 - Lower Respiratory Tract Panel Product Overview
  • FilmArray 2.0 - Lower Respiratory Tract Panel Clinical Trial
  • FilmArray Febrile Infant Panel
  • FilmArray Febrile Infant Panel Product Overview
  • FilmArray Sepsis Direct Panel
  • FilmArray Sepsis Direct Panel Product Overview
  • FilmArray STD Panel
  • FilmArray STD Panel Product Overview
  • BioFire Diagnostics Inc - Key Competitors
  • BioFire Diagnostics Inc - Key Employees
  • BioFire Diagnostics Inc - Locations And Subsidiaries
  • Head Office
Recent Developments
  • BioFire Diagnostics Inc, Recent Developments
  • Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
  • Jan 14, 2020: bioMerieux submits enhanced BIOFIRE BCID2 panel for FDA clearance
  • Apr 04, 2019: Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections
  • Apr 01, 2019: New reimbursement codes for BIOFIRE FILMARRAY Respiratory and Gastrointestinal Panels
  • Feb 05, 2019: Entasis Therapeutics announces rapid diagnostic agreement with bioMerieux
  • Nov 13, 2018: bioMerieux launches the BIOFIRE FILMARRAY Pneumonia Panels with FDA clearance and CE marking
  • Apr 19, 2018: bioMerieux submits for FDA Clearance of the BIOFIRE FILMARRAY Pneumonia Panel
  • Jun 01, 2017: bioMérieux receives FDA Clearance for BioFire’s FilmArray Respiratory Panel 2 (RP2)
  • Apr 20, 2017: bioMerieux: The FilmArray Respiratory Panel 2 plus (RP2plus) Gets CE Marked
  • Nov 04, 2016: Protecting our troops from disease: FDA approves early detection and diagnosis device
Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • BioFire Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • BioFire Diagnostics Inc Pipeline Products by Equipment Type
  • BioFire Diagnostics Inc Pipeline Products by Indication
  • BioFire Diagnostics Inc Ongoing Clinical Trials by Trial Status
  • BioFire Diagnostics Inc, Key Facts
  • BioFire Diagnostics Inc, Major Products and Services
  • BioFire Diagnostics Inc Number of Pipeline Products by Development Stage
  • BioFire Diagnostics Inc Pipeline Products Summary by Development Stage
  • BioFire Diagnostics Inc Ongoing Clinical Trials by Trial Status
  • BioFire Diagnostics Inc Ongoing Clinical Trials Summary
  • Diagnostic Test - Acute Respiratory Infection - Product Status
  • Diagnostic Test - Acute Respiratory Infection - Product Description
  • FilmArray 2.0 - Lower Respiratory Tract Panel - Product Status
  • FilmArray 2.0 - Lower Respiratory Tract Panel - Product Description
  • FilmArray 2.0 - Lower Respiratory Tract Panel - Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-acquired Pneumonia
  • FilmArray Febrile Infant Panel - Product Status
  • FilmArray Febrile Infant Panel - Product Description
  • FilmArray Sepsis Direct Panel - Product Status
  • FilmArray Sepsis Direct Panel - Product Description
  • FilmArray STD Panel - Product Status
  • FilmArray STD Panel - Product Description
  • BioFire Diagnostics Inc, Key Employees
  • Glossary
List of Figures
  • BioFire Diagnostics Inc Pipeline Products by Equipment Type
  • BioFire Diagnostics Inc Pipeline Products by Development Stage
  • BioFire Diagnostics Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • Remel Inc
  • Erba Diagnostics Inc
  • Edge Biologicals, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll